March 23 (Reuters) – Drugmaker Novartis AG agreed on Wednesday to pay more than $25 million to the U.S. government to settle civil charges that it bribed healthcare professionals in China to boost…
The post Novartis settles charges alleging bribery in China – SEC appeared first on NASDAQ.